Advertisements


NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback

NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback.....»»

Category: topSource: seekingalphaMay 17th, 2018

NewLink Genetics" Potential Catalysts Not Enough To Justify A Bullish Stance, Baird Says In Downgrade

NewLink Genetics Corp (NASDAQ: NLNK) said Friday it will review the clinical programs for its indoximod therapy after rival Incyte Corporation (NASDAQ: INCY) Latest Ratings for .....»»

Category: blogSource: benzingaApr 9th, 2018

Roche terminates Genentech collaboration agreement with NewLink Genetics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018

Alpine: Explicating The Upcoming Catalysts Powering Robust Potential For This Stock

Alpine: Explicating The Upcoming Catalysts Powering Robust Potential For This Stock.....»»

Category: topSource: seekingalphaMay 10th, 2018

Social Security could go bankrupt if this happens

Changing one key aspect has the potential to destabilize the whole program......»»

Category: topSource: moneycentralMay 5th, 2018

Deliveroo CEO: We"re changing how people eat

London-based Deliveroo is changing the food delivery industry. CNN's Samuel Burke sat down with CEO and co-founder Will Shu to talk gig-economy, Brexit and the company's potential IPO......»»

Category: videoSource: cnnMay 3rd, 2018

NewLink Genetics reports Q1 EPS (49c), consensus (55c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Worst over for Coca-Cola? Multi-front strategy boosts sales in India

The seeds of a potential turnaround were sown in 2016, when the firm began to revamp its portfolio to match changing consumer needs.....»»

Category: topSource: business-standardApr 27th, 2018

Worst over for Coca-Cola: Multi-front strategy boosts sales in India

The seeds of a potential turnaround were sown in 2016, when the firm began to revamp its portfolio to match changing consumer needs.....»»

Category: topSource: business-standardApr 26th, 2018

3 Energy Stocks to Buy for an Oil Breakout

Oil's fundamentals are changing for the better. And you don't need to trade futures to climb aboard......»»

Category: topSource: moneycentralApr 23rd, 2018

Blockchain initiatives emerge in WNY

You may have heard that blockchain is changing the world. Even if you don’t understand what blockchain is or why it’s important, rest assured that a growing group in Buffalo sees big potential in this emerging technology......»»

Category: topSource: bizjournalsApr 20th, 2018

Why NewLink Genetics Shares Hit an All-Time Low

NewLink Genetics shares hit an all-time low in Monday’s session after the company provided an update on its brain tumor trial......»»

Category: blogSource: 247wallstApr 16th, 2018

NewLink shares fall on late-stage trial changes

NewLink Genetics Corp. shares fell as much as 15% in premarket trade Monday after the company said it won't proceed as planned with a late-stage trial of its indoximod for advanced melanoma. The company will inst.....»»

Category: topSource: marketwatchApr 16th, 2018

NewLink Shares Plunge After Incyte & Merck"s Study Fails

Shares of NewLink Genetics Corp. (NLNT) plunged about 42.6% following the news of the failure of Incyte and Merck's phase III .....»»

Category: smallbizSource: nytApr 9th, 2018

Cantor Fitzgerald Double Downgrades NewLink Genetics After Incyte"s Disappointing Trial

NewLink Genetics Corp (NASDAQ: NLNK), a late-stage biopharmaceutical company that focuses on cancer treatments, said on Friday it will review its clinical program after Merck & Co., Inc. (NYSE: Latest Ratings for .....»»

Category: blogSource: benzingaApr 9th, 2018

NewLink Genetics downgraded to Neutral at Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

NewLink Genetics downgraded to Hold at SunTrust on Incyte trial failure

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

NewLink Genetics downgraded to Neutral from Overweight at Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

NewLink Genetics downgraded to Hold with $4 target at Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

Rigel Fumbles A Phase 2, Can Stage A Potential Comeback With FDA Approval

Rigel Fumbles A Phase 2, Can Stage A Potential Comeback With FDA Approval.....»»

Category: topSource: seekingalphaApr 9th, 2018

NewLink Genetics downgraded to Neutral from Outperform at Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018